Showing results (271-280 of 464) with videos related to

Sort By:
Pageof 47
Frontiers in Oncology|March 30, 2019
Disease Control With FOLFIRI Plus Ziv-aflibercept (zFOLFIRI) Beyond FOLFIRI Plus Bevacizumab: Case Series in Metastatic Colorectal Cancer (mCRC)Wafik S El-Deiry, Arthur Winer, Michael Slifker, et al.
Experimental Cell Research|September 15, 1996
p21 (WAF1/CIP1) expression is induced in newly nondividing cells in diverse epithelia and during differentiation of the Caco-2 intestinal cell lineA L Gartel, M S Serfas, M Gartel, et al.
Molecular Cancer|May 1, 2015
Identification of TRAIL-inducing compounds highlights small molecule ONC201/TIC10 as a unique anti-cancer agent that activates the TRAIL pathwayJoshua E Allen, Gabriel Krigsfeld, Luv Patel, et al.
Oncogene|December 22, 1999
BRCA1 signals ARF-dependent stabilization and coactivation of p53K Somasundaram, T K MacLachlan, T F Burns, et al.
The Journal of Clinical Endocrinology and Metabolism|March 17, 2005
p53-Dependent and p53-independent induction of insulin-like growth factor binding protein-3 by deoxyribonucleic acid damage and hypoxiaAdda Grimberg, Carrie M Coleman, Timothy F Burns, et al.
Cell Cycle (Georgetown, Tex.)|October 4, 2007
Replication stress, defective S-phase checkpoint and increased death in Plk2-deficient human cancer cellsElizabeth M Matthew, Timothy J Yen, David T Dicker, et al.
Cancer Research|January 14, 2016
Small-Molecule Prodigiosin Restores p53 Tumor Suppressor Activity in Chemoresistant Colorectal Cancer Stem Cells via c-Jun-Mediated ΔNp73 Inhibition and p73 ActivationVarun V Prabhu, Bo Hong, Joshua E Allen, et al.
Cancer Biology & Therapy|October 26, 2021
Antitumorigenic effect of combination treatment with ONC201 and TRAIL in endometrial cancer in vitro and in vivoJocelyn E Ray, Marie D Ralff, Aakash Jhaveri, et al.
American Journal of Cancer Research|October 17, 2024
Synergistic anti-tumor activity, reduced pERK, and immuno-stimulatory cytokine profiles with 5-FU or ONC212 plus KRAS G12D inhibitor MRTX1133 in CRC and pancreatic cancer cells independent of G12D mutationVida Tajiknia, Maximilian Pinho-Schwermann, Praveen R Srinivasan, et al.
Molecular Cancer Research : MCR|March 29, 2018
ONC201 Targets AR and AR-V7 Signaling, Reduces PSA, and Synergizes with Everolimus in Prostate CancerAvital Lev, Amriti R Lulla, Brian C Ross, et al.
Pageof 47